|
Background
|
Parkinson is the second most common neurodegenerative disease after Alzheimers. About 1 percent of people over the age of 65 and 3 percent of people over the age of 75 are affected by the disease. The mutation is the most common cause of Parkinson's disease identified to date. LRRK2, a genetic mutation, was recently found linked to about 5 percent of inherited cases of Parkinson's disease. By high-resolution recombination mapping and candidate gene sequencing in 46 families, 6 disease-segregating mutations (5 missense and 1 putative splice site mutation). It may be central to the pathogenesis of several major neurodegenerative disorders associated with parkinsonism. LRRK2 belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains.
|
Background
References
|
- Shen J. Neuron. 2004. 44:575.
- Paisan-Ruiz C, et al. Neuron. 2004. 44(4):595.
- Zimprich A, et al. Neuron. 2004. 44(4):601.
- Wszolek ZK, et al. Neurology. 2004. 62(9):1619.
- Park YJ, et al. Transplant Proc. 2004. 36(2):353.
- Zimprich A, et al. Am J Hum Genet. 2004. 74:11.
- Bonifati V. Lancet Neurol. 2002. 1:83.
- Funayama M, et al.Ann Neurol. 2002. 51:296.
|
Order Information
List Price (USA): $235.00/0.1mg
Related Products
Data Rewards Program
